Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Pharmacy and Pharmaceutical Sciences

PDF

Pharmaceutical Sciences ETDs

Theses/Dissertations

Opioid

Publication Year

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

Serotonin Syndrome And/Or Opioid Withdrawal After The First Dose Of Naltrexone Hcl/Bupropion Hcl: An Observational Study, Stefanie J. Logothetis May 2019

Serotonin Syndrome And/Or Opioid Withdrawal After The First Dose Of Naltrexone Hcl/Bupropion Hcl: An Observational Study, Stefanie J. Logothetis

Pharmaceutical Sciences ETDs

In 2014, the Food and Drug Administration approved naltrexone HCl/bupropion HCl, a combination of an antidepressant and an opioid antagonist for chronic weight management therapy. Concurrent use of antidepressants and opioids has the potential to cause drug interactions involving serotonin syndrome. Our primary objective is to identify cases of serotonin syndrome and/or opioid withdrawal after initiation of naltrexone HCl/bupropion HCl. Our secondary objective is to assess which specific opioids are more likely to cause a drug interaction with naltrexone HCl/bupropion HCl. We performed an observational study by reviewing cases in the RADARS® database from January 2014 through December 2018. …


Assessing The Impact Of Prescription Opioid Use Versus No Use On Adherence To Chronic Obstructive Pulmonary Disease (Copd) Maintenance Medications, Copd Exacerbations And Total Healthcare Costs, Akshay Kharat Nov 2018

Assessing The Impact Of Prescription Opioid Use Versus No Use On Adherence To Chronic Obstructive Pulmonary Disease (Copd) Maintenance Medications, Copd Exacerbations And Total Healthcare Costs, Akshay Kharat

Pharmaceutical Sciences ETDs

OBJECTIVES:COPD contributes significant morbidity and mortality worldwide and is currently the third leading cause of mortality in the United States. Chronic pain prevalence is high among COPD patients leading to a high rate of prescription opioid use. The potential impact of concurrent prescription opioid use on COPD maintenance medication adherence, COPD exacerbations, and total healthcare costs is not well understood. The study objectives were i) to assess the impact of prescription opioid use compared to no prescription opioid use on COPD maintenance medication adherence in 90, 180, 270, and 365-day follow-up periods, and ii) to assess the impact of …